A case of clinical tetanus in a patient with protective antitetanus antibody level [1]

Southern Medical Journal

Volumn 100, Issue 1, 2007, Pages 83-

  Beltran, Alvaro ^a   Go, Eddie ^b   Haq, Mahenaaz ^b   Clarke, Hillary B ^b   Zaman, Muhammad ^b   Recco, Rose A ^b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b State University of New York Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; TETANUS ANTIBODY; TETANUS TOXOID;

ADULT; CASE REPORT; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; HUMAN; IMMUNOASSAY; IMMUNOTHERAPY; LETTER; LEUKOCYTE COUNT; MALE; TETANUS; TETANUS PROPHYLAXIS; WOUND;

ANTIBODIES, BACTERIAL; CLOSTRIDIUM TETANI; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; TETANUS; TETANUS ANTITOXIN;

EID: 33846191124     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31802e2717     Document Type: Letter

References (5)

1. Pascual FB, McGinley EL, Zanardi LR, et al. Tetanus surveillance-United States, 1998-2000. MMWR Surveill Summ 2003;52:1-8.
2. Sneath PAT, Kerslake EG, Scruby F. Tetanus immunity: the resistance of guinea pigs to lethal spore doses induced by active and passive immunization. Am J Hyg 1937;25:464-476.
3. Crone N, Reder A. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology 1992;42:761-764.
4. Berger SA, Cherubin CE, Nelson S. Tetanus despite preexisting antitetanus antibody. JAMA 1978;240:769-770
5. Atkinson WL, Pickering LK, Schwartz B, et al. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002;51:1-35.